secwatch.observer — SEC 8-K summary
======================================

Issuer:     MASIMO CORP (MASI)
CIK:        0000937556
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0000937556-24-000040
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Masimo Q1 rev $492.8M (healthcare $339.6M), GAAP EPS $0.35, Non-GAAP $0.77; lifts FY2024 outlook
--------------------------------------------------------------------------------

- Consolidated Q1 revenue $492.8M; healthcare $339.6M, non-healthcare $153.2M.
- GAAP net income $18.9M ($0.35 diluted EPS); non-GAAP net income $41.9M ($0.77 diluted EPS).
- Sensor manufacturing shift from Mexico to Malaysia improved healthcare gross margins ahead of schedule.
- Raises FY2024 healthcare revenue guidance to $1.355-1.385B and non-GAAP EPS to $3.54-3.70.
- Pursuing separation of consumer business; management finalizing structure for board review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000040/0000937556-24-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/937556/000093755624000040/masi-20240507.htm
  HTML page:      https://secwatch.observer/filing/0000937556-24-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer